The family office provides strategic and operational support for the founding individual’s investment initiatives and entrepreneurial endeavors. The firm has a history of successful investments in well-known companies. The firm invests from seed to pre-IPO companies worldwide.
The fund is agnostic across life science sectors, including platforms, therapeutics, devices and tools, and services and including discovery, early stage preclinical and clinical-stage opportunities, though open to commercial-stage or adjacent discovery/development technologies.
The firm seeks companies with founders who have a clear vision, highly differentiated technology, and desire to build a durable business.
If you are interested in more information about this investor and other investors tracked by LSN, please email LHI@lifesciencenation.com.
Leave a Reply